Is Leap Therapeutics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: LPTX) stock is to Strong Buy LPTX stock.
Out of 2 analysts, 1 (50%) are recommending LPTX as a Strong Buy, 1 (50%) are recommending LPTX as a Buy, 0 (0%) are recommending LPTX as a Hold, 0 (0%) are recommending LPTX as a Sell, and 0 (0%) are recommending LPTX as a Strong Sell.
What is LPTX's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: LPTX) forecast ROE is N/A, which is considered weak.
What is LPTX's Price Target?
According to 2 Wall Street analysts that have issued a 1 year LPTX price target, the average LPTX price target is $2.25, with the highest LPTX stock price forecast at $2.50 and the lowest LPTX stock price forecast at $2.00.
On average, Wall Street analysts predict that Leap Therapeutics's share price could reach $2.25 by May 16, 2024. The average Leap Therapeutics stock price prediction forecasts a potential upside of 155.68% from the current LPTX share price of $0.88.
What is LPTX's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: LPTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.12%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.